Cystic fibrosis treatment recommended by NICE

We’ve published final guidance today (24 July 2024) recommending cystic fibrosis (CF) treatments Kaftrio, Symkevi, and Orkambi, following a new commercial deal between NHS England and Vertex.

This collaboration highlights our dedication to providing the best care for CF patients, with a focus on rapid access to new and effective treatments.

Our appraisal of CF medicines marks one of the first instances non-cancer treatments have received additional weighting with the new severity modifier, a key factor in our recommendation.

#CysticFibrosis #NHS #PatientCare